SubsidieMeesters logoSubsidieMeesters
ProjectenRegelingenAnalyses

Interrogating basal ganglia reinforcement with deep brain stimulation in Parkinson’s disease.

ReinforceBG aims to explore dopamine's role in Parkinson's disease through advanced neuromodulation techniques to enhance understanding and develop innovative treatments for motor and cognitive symptoms.

Subsidie
€ 1.499.580
2023

Projectdetails

Introduction

Dopamine and the basal ganglia have been conserved over more than 500 million years of evolution. They are fundamental to animal and human behaviour. Parkinson's disease (PD) is associated with loss of dopaminergic innervation to the basal ganglia. Over 6 million people suffer from the debilitating symptoms of PD that span disturbance of emotion, cognition, and movement.

Need for Understanding

There is a pressing need to understand the pathogenesis of these symptoms, but an integrated account of dopamine and basal ganglia function is lacking. This constitutes a significant roadblock to scientific and therapeutic advances.

Novel Hypothesis

To overcome this roadblock, ReinforceBG poses the novel unconventional hypothesis that loss of dopamine in PD does not impair movement per se but leads to chronic negative reinforcement of neural population dynamics. Conversely, in the healthy state, transient dopamine signals may stabilize cortex-basal ganglia activity to facilitate reentry and refinement of cortical output.

Research Methodology

To address this hypothesis, ReinforceBG will combine invasive electrocorticography and local field potential recordings with closed-loop deep brain stimulation in PD patients.

Aims of the Project

  1. Aim 1: Investigate how basal ganglia pathways coordinate neuromuscular adaptation.
  2. Aim 2: Shed light on basal ganglia reinforcement in multiple behavioural domains, including movement, gait, speech, and spatial navigation in virtual reality.
  3. Aim 3: Develop a neuroprosthetic brain-computer interface that aims to modulate basal ganglia reinforcement.

Innovative Approach

ReinforceBG deviates from outdated models on pro- vs. antikinetic Go and NoGo pathways and promises a holistic-reinforcement centred view of basal ganglia function. It will leverage the unprecedented spatiotemporal precision of neuromodulation for the development of an innovative brain circuit intervention that modulates neural reinforcement in real time.

Future Implications

This opens new horizons for the interdisciplinary treatment of brain disorders affecting the dopaminergic system.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.499.580
Totale projectbegroting€ 1.499.580

Tijdlijn

Startdatum1-3-2023
Einddatum29-2-2028
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • CHARITE - UNIVERSITAETSMEDIZIN BERLINpenvoerder

Land(en)

Germany

Inhoudsopgave

European Research Council

Financiering tot €10 miljoen voor baanbrekend frontier-onderzoek via ERC-grants (Starting, Consolidator, Advanced, Synergy, Proof of Concept).

Bekijk regeling

Vergelijkbare projecten binnen European Research Council

ProjectRegelingBedragJaarActie

Atlas of the Human Deep Brain Nuclei, Connections, and Vasculature

The project aims to create an atlas of human deep brain nuclei and vasculature to enhance deep-brain stimulation outcomes and minimize side effects in movement and neuropsychiatric disorders.

ERC Proof of...€ 150.000
2023
Details

Desynchronizing weak cortical fields during deep brain stimulation

DECODE aims to enhance deep brain stimulation for Parkinson's by investigating weak electric fields' role in desynchronizing neural activity to improve motor control and reduce side effects.

ERC Starting...€ 1.498.914
2024
Details

Dissecting the biophysical mechanisms of deep brain stimulation using voltage fluorescence microscopy

This project aims to elucidate the cellular mechanisms of deep brain stimulation in epilepsy using a novel optical technique to improve therapeutic protocols for human patients.

ERC Starting...€ 1.498.729
2024
Details

Neuromodulatory control of brain network dynamics

This project aims to uncover the physiological mechanisms of spontaneous brain network dynamics in awake mice through advanced neuromodulation techniques, with implications for neuroscience.

ERC Consolid...€ 1.999.438
2025
Details

Bidirectional Brain/Neural-Computer Interaction for Restoration of Mental Health

This project aims to develop a portable neuromodulation system using quantum sensors and magnetic stimulation to precisely target brain oscillations for treating mental health disorders.

ERC Consolid...€ 1.999.875
2025
Details
ERC Proof of...

Atlas of the Human Deep Brain Nuclei, Connections, and Vasculature

The project aims to create an atlas of human deep brain nuclei and vasculature to enhance deep-brain stimulation outcomes and minimize side effects in movement and neuropsychiatric disorders.

ERC Proof of Concept
€ 150.000
2023
Details
ERC Starting...

Desynchronizing weak cortical fields during deep brain stimulation

DECODE aims to enhance deep brain stimulation for Parkinson's by investigating weak electric fields' role in desynchronizing neural activity to improve motor control and reduce side effects.

ERC Starting Grant
€ 1.498.914
2024
Details
ERC Starting...

Dissecting the biophysical mechanisms of deep brain stimulation using voltage fluorescence microscopy

This project aims to elucidate the cellular mechanisms of deep brain stimulation in epilepsy using a novel optical technique to improve therapeutic protocols for human patients.

ERC Starting Grant
€ 1.498.729
2024
Details
ERC Consolid...

Neuromodulatory control of brain network dynamics

This project aims to uncover the physiological mechanisms of spontaneous brain network dynamics in awake mice through advanced neuromodulation techniques, with implications for neuroscience.

ERC Consolidator Grant
€ 1.999.438
2025
Details
ERC Consolid...

Bidirectional Brain/Neural-Computer Interaction for Restoration of Mental Health

This project aims to develop a portable neuromodulation system using quantum sensors and magnetic stimulation to precisely target brain oscillations for treating mental health disorders.

ERC Consolidator Grant
€ 1.999.875
2025
Details

Vergelijkbare projecten uit andere regelingen

ProjectRegelingBedragJaarActie

Opto-Electronic Neural Connectoid Model Implemented for Neurodegenerative Disease

The project aims to develop a novel human brain-organoid model, called connectoids, to replace animal testing for Parkinson's disease, enhancing therapy monitoring and reducing societal burdens.

EIC Pathfinder€ 2.992.203
2022
Details

Revolutionary therapeutic treatment for stopping progression of Parkinson's disease

Herantis is developing HER-096, a novel pharmaceutical aimed at modifying Parkinson's disease pathology to alleviate symptoms and reduce the societal burden of the condition.

EIC Accelerator€ 2.500.000
2023
Details

Adpative DBS

AlphaDBS enhances DBS treatment for Parkinson's by using adaptive stimulation based on local field potentials to optimize energy delivery in real-time.

EIC Accelerator€ 2.499.999
2023
Details

Distributed and federated cross-modality actuation through advanced nanomaterials and neuromorphic learning

CROSSBRAIN aims to revolutionize brain condition treatment using implantable microbots for real-time, adaptive neuromodulation and sensing in rodent models of Parkinson's Disease and Epilepsy.

EIC Pathfinder€ 4.034.074
2022
Details

Mapping the brain-spinal cord interaction towards understanding and treatment of movement disorders

Move2Treat aims to develop a novel bi-directional brain-spinal cord interface to enhance understanding and treatment of movement disorders through advanced neuronal circuit mapping.

EIC Pathfinder€ 2.996.048
2024
Details
EIC Pathfinder

Opto-Electronic Neural Connectoid Model Implemented for Neurodegenerative Disease

The project aims to develop a novel human brain-organoid model, called connectoids, to replace animal testing for Parkinson's disease, enhancing therapy monitoring and reducing societal burdens.

EIC Pathfinder
€ 2.992.203
2022
Details
EIC Accelerator

Revolutionary therapeutic treatment for stopping progression of Parkinson's disease

Herantis is developing HER-096, a novel pharmaceutical aimed at modifying Parkinson's disease pathology to alleviate symptoms and reduce the societal burden of the condition.

EIC Accelerator
€ 2.500.000
2023
Details
EIC Accelerator

Adpative DBS

AlphaDBS enhances DBS treatment for Parkinson's by using adaptive stimulation based on local field potentials to optimize energy delivery in real-time.

EIC Accelerator
€ 2.499.999
2023
Details
EIC Pathfinder

Distributed and federated cross-modality actuation through advanced nanomaterials and neuromorphic learning

CROSSBRAIN aims to revolutionize brain condition treatment using implantable microbots for real-time, adaptive neuromodulation and sensing in rodent models of Parkinson's Disease and Epilepsy.

EIC Pathfinder
€ 4.034.074
2022
Details
EIC Pathfinder

Mapping the brain-spinal cord interaction towards understanding and treatment of movement disorders

Move2Treat aims to develop a novel bi-directional brain-spinal cord interface to enhance understanding and treatment of movement disorders through advanced neuronal circuit mapping.

EIC Pathfinder
€ 2.996.048
2024
Details

SubsidieMeesters logoSubsidieMeesters

Vind en verken subsidieprojecten in Nederland en Europa.

Links

  • Projecten
  • Regelingen
  • Analyses

Suggesties

Heb je ideeën voor nieuwe features of verbeteringen?

Deel je suggestie
© 2025 SubsidieMeesters. Alle rechten voorbehouden.